This Week on Drug Topics: August 9 to August 13
Here’s a preview of the featured content to watch for this week on Drug Topics®.
Expert Interviews: Part 3: Ken Perez Medicare Part B Legislation for Provider Status for Pharmacists
Ken Perez, MBA, vice president of healthcare policy and government affairs at Omnicell, discussed the crucial points of pharmacist provider status in Medicare Part B, which would allow pharmacists in underserved communities to be reimbursed for certain primary care services that they already provide in commercially ensured populations.
Drug Topics® Journal, August 2021 Digital Edition
The August 2021 digital edition of Drug Topics Journal will soon be available on DrugTopics.com. In this issue, you’ll find articles on flu point-of-care (POC) testing and vaccinations, psoriasis management, naloxone counseling, and more.
Read the latest issue of Drug Topics Journal.
The latest from Total Pharmacy®: What Pharmacist eCare Plan Really Can Do for You
Pharmacist eCare Plan (PeCP) is one of the hottest buzzwords in pharmacy. Proponents call the PeCP the greatest innovation in pharmacy technology since electronic prescribing.
Trending on Drug Topics®: Gut Health Survey
Drug Topics® is creating educational opportunities regarding occasional constipation, and your insight will help us to better serve your educational needs.
Participate in the survey now!
In Case You Missed It: First Interchangeable Biosimilar Insulin Approved by FDA for Diabetes
The FDA has granted approval of the first interchangeable biosimilar insulin product, insulin glargine-yfgn (Semglee; Mylan Pharmaceuticals), for diabetes.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
